tiprankstipranks
Globus Medical (DE:GM0N)
NYSE:GM0N
Germany Market
GM0N
Globus Medical
RESEARCH TOOLSreports

Globus Medical (GM0N) Stock Forecast & Price Target

1 Followers
See the Price Targets and Ratings of:

GM0N Analyst Ratings

Strong Buy
11Ratings
Strong Buy
9 Buy
2 Hold
0 Sell
Based on 11 analysts giving stock ratings to
Globus
Medical
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

GM0N Stock 12 Month Forecast

Average Price Target

€93.85
▲(20.59% Upside)
Based on 11 Wall Street analysts offering 12 month price targets for Globus Medical in the last 3 months. The average price target is €93.85 with a high forecast of €107.99 and a low forecast of €70.24. The average price target represents a 20.59% change from the last price of €77.82.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"44":"€44","60":"€60","76":"€76","92":"€92","108":"€108"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":107.99154984,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€107.99</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":93.84631521777779,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€93.85</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":70.2384064,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€70.24</span>\n  </div></div>","useHTML":true}}],"tickPositions":[44,60,76,92,108],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,68.32,71.37165768,74.42331535999999,77.47497304,80.52663072,83.57828839999999,86.62994608,89.68160376,92.73326144,95.78491912,98.8365768,101.88823448,104.93989216,{"y":107.99154984,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,68.32,70.28356270905982,72.24712541811965,74.21068812717948,76.17425083623931,78.13781354529914,80.10137625435897,82.0649389634188,84.02850167247864,85.99206438153847,87.9556270905983,89.91918979965813,91.88275250871796,{"y":93.84631521777779,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,68.32,68.46756972307692,68.61513944615385,68.76270916923076,68.91027889230769,69.05784861538461,69.20541833846154,69.35298806153845,69.50055778461538,69.64812750769231,69.79569723076924,69.94326695384615,70.09083667692308,{"y":70.2384064,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":49.4,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":45.4,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":51.5,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":48,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":52.5,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":78,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":74.5,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":75,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":80,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":74,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":74.1,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":69.6,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":68.32,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target€107.99Average Price Target€93.85Lowest Price Target€70.24
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
RBC Capital Analyst forecast on DE:GM0N
Shagun Singh Chadha
RBC Capital
RBC Capital
€105.36→€100.97
Buy
29.75%
Upside
Reiterated
07/13/26
Globus Medical price target lowered to $115 from $120 at RBC CapitalGlobus Medical price target lowered to $115 from $120 at RBC Capital
BTIG Analyst forecast on DE:GM0N
Ryan Zimmerman
BTIG
BTIG
―
Hold
―
Reiterated
07/10/26
BTIG Keeps Their Hold Rating on Globus Medical (GMED)
Wells Fargo Analyst forecast on DE:GM0N
Vik Chopra
Wells Fargo
Wells Fargo
€82.53
Buy
6.05%
Upside
Initiated
07/09/26
Globus Medical initiated with an Outperform at BMO CapitalGlobus Medical initiated with an Outperform at BMO Capital
Stifel Nicolaus Analyst forecast on DE:GM0N
Thomas Stephan
Stifel Nicolaus
Stifel Nicolaus
€83.41→€70.24
Hold
-9.74%
Downside
Assigned
07/08/26
Globus Medical price target lowered to $80 from $95 at StifelGlobus Medical price target lowered to $80 from $95 at Stifel
TD Cowen Analyst forecast on DE:GM0N
Mathew Blackman
TD Cowen
TD Cowen
€100.97
Buy
29.75%
Upside
Reiterated
06/22/26
Globus Medical Buy Rating Reiterated on Underappreciated Growth and Earnings Power; Price Target Maintained at $115
Piper Sandler Analyst forecast on DE:GM0N
Matthew O'Brien
Piper Sandler
Piper Sandler
€100.97→€87.8
Buy
12.82%
Upside
Reiterated
06/15/26
Globus Medical price target lowered to $100 from $115 at Piper SandlerGlobus Medical price target lowered to $100 from $115 at Piper Sandler
Barclays Analyst forecast on DE:GM0N
Matt Miksic
Barclays
Barclays
€107.99
Buy
38.77%
Upside
Reiterated
05/11/26
Analysts Offer Insights on Healthcare Companies: Hims & Hers Health (NYSE: HIMS), BridgeBio Pharma (NASDAQ: BBIO) and Globus Medical (NYSE: GMED)
Truist Financial Analyst forecast on DE:GM0N
Richard Newitter
Truist Financial
Truist Financial
―
Buy
―
Reiterated
05/08/26
Analysts' Top Healthcare Picks: Maravai Lifesciences Holdings (MRVI), Globus Medical (GMED)
Canaccord Genuity Analyst forecast on DE:GM0N
Caitlin Cronin
Canaccord Genuity
Canaccord Genuity
€100.97
Buy
29.75%
Upside
Reiterated
05/08/26
Canaccord Genuity Sticks to Their Buy Rating for Globus Medical (GMED)
Wells Fargo Analyst forecast on DE:GM0N
Larry Biegelsen
Wells Fargo
Wells Fargo
€91.31→€90.43
Buy
16.21%
Upside
Reiterated
05/08/26
Wells Fargo Reaffirms Their Buy Rating on Globus Medical (GMED)
Needham Analyst forecast on DE:GM0N
David Saxon
Needham
Needham
€100.09→€102.72
Buy
32.00%
Upside
Reiterated
05/08/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Bank of America Securities Analyst forecast on DE:GM0N
Travis Steed
Bank of America Securities
Bank of America Securities
€93.07
Buy
19.59%
Upside
Reiterated
02/25/26
Bank of America Securities Sticks to Its Buy Rating for Globus Medical (GMED)
Morgan Stanley Analyst forecast on DE:GM0N
Patrick Wood
Morgan Stanley
Morgan Stanley
€87.8
Buy
12.82%
Upside
Reiterated
02/25/26
Globus Medical: Sustained Outperformance, Margin Expansion, and Acquisition Synergies Support Buy Rating
Jefferies Analyst forecast on DE:GM0N
Matthew Taylor
Jefferies
Jefferies
€92.19→€100.97
Buy
29.75%
Upside
Reiterated
01/08/26
Jefferies Sticks to Its Buy Rating for Globus Medical (GMED)
Freedom Capital Markets Analyst forecast on DE:GM0N
Keith Hinton
Freedom Capital Markets
Freedom Capital Markets
€76.38
Hold
-1.84%
Downside
Initiated
12/16/25
Analysts Offer Insights on Healthcare Companies: Novan (NASDAQ: NOVN) and Globus Medical (NYSE: GMED)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
RBC Capital Analyst forecast on DE:GM0N
Shagun Singh Chadha
RBC Capital
RBC Capital
€105.36→€100.97
Buy
29.75%
Upside
Reiterated
07/13/26
Globus Medical price target lowered to $115 from $120 at RBC CapitalGlobus Medical price target lowered to $115 from $120 at RBC Capital
BTIG Analyst forecast on DE:GM0N
Ryan Zimmerman
BTIG
BTIG
―
Hold
―
Reiterated
07/10/26
BTIG Keeps Their Hold Rating on Globus Medical (GMED)
Wells Fargo Analyst forecast on DE:GM0N
Vik Chopra
Wells Fargo
Wells Fargo
€82.53
Buy
6.05%
Upside
Initiated
07/09/26
Globus Medical initiated with an Outperform at BMO CapitalGlobus Medical initiated with an Outperform at BMO Capital
Stifel Nicolaus Analyst forecast on DE:GM0N
Thomas Stephan
Stifel Nicolaus
Stifel Nicolaus
€83.41→€70.24
Hold
-9.74%
Downside
Assigned
07/08/26
Globus Medical price target lowered to $80 from $95 at StifelGlobus Medical price target lowered to $80 from $95 at Stifel
TD Cowen Analyst forecast on DE:GM0N
Mathew Blackman
TD Cowen
TD Cowen
€100.97
Buy
29.75%
Upside
Reiterated
06/22/26
Globus Medical Buy Rating Reiterated on Underappreciated Growth and Earnings Power; Price Target Maintained at $115
Piper Sandler Analyst forecast on DE:GM0N
Matthew O'Brien
Piper Sandler
Piper Sandler
€100.97→€87.8
Buy
12.82%
Upside
Reiterated
06/15/26
Globus Medical price target lowered to $100 from $115 at Piper SandlerGlobus Medical price target lowered to $100 from $115 at Piper Sandler
Barclays Analyst forecast on DE:GM0N
Matt Miksic
Barclays
Barclays
€107.99
Buy
38.77%
Upside
Reiterated
05/11/26
Analysts Offer Insights on Healthcare Companies: Hims & Hers Health (NYSE: HIMS), BridgeBio Pharma (NASDAQ: BBIO) and Globus Medical (NYSE: GMED)
Truist Financial Analyst forecast on DE:GM0N
Richard Newitter
Truist Financial
Truist Financial
―
Buy
―
Reiterated
05/08/26
Analysts' Top Healthcare Picks: Maravai Lifesciences Holdings (MRVI), Globus Medical (GMED)
Canaccord Genuity Analyst forecast on DE:GM0N
Caitlin Cronin
Canaccord Genuity
Canaccord Genuity
€100.97
Buy
29.75%
Upside
Reiterated
05/08/26
Canaccord Genuity Sticks to Their Buy Rating for Globus Medical (GMED)
Wells Fargo Analyst forecast on DE:GM0N
Larry Biegelsen
Wells Fargo
Wells Fargo
€91.31→€90.43
Buy
16.21%
Upside
Reiterated
05/08/26
Wells Fargo Reaffirms Their Buy Rating on Globus Medical (GMED)
Needham Analyst forecast on DE:GM0N
David Saxon
Needham
Needham
€100.09→€102.72
Buy
32.00%
Upside
Reiterated
05/08/26
Wall Street Analysts Are Bullish on Top Healthcare Picks
Bank of America Securities Analyst forecast on DE:GM0N
Travis Steed
Bank of America Securities
Bank of America Securities
€93.07
Buy
19.59%
Upside
Reiterated
02/25/26
Bank of America Securities Sticks to Its Buy Rating for Globus Medical (GMED)
Morgan Stanley Analyst forecast on DE:GM0N
Patrick Wood
Morgan Stanley
Morgan Stanley
€87.8
Buy
12.82%
Upside
Reiterated
02/25/26
Globus Medical: Sustained Outperformance, Margin Expansion, and Acquisition Synergies Support Buy Rating
Jefferies Analyst forecast on DE:GM0N
Matthew Taylor
Jefferies
Jefferies
€92.19→€100.97
Buy
29.75%
Upside
Reiterated
01/08/26
Jefferies Sticks to Its Buy Rating for Globus Medical (GMED)
Freedom Capital Markets Analyst forecast on DE:GM0N
Keith Hinton
Freedom Capital Markets
Freedom Capital Markets
€76.38
Hold
-1.84%
Downside
Initiated
12/16/25
Analysts Offer Insights on Healthcare Companies: Novan (NASDAQ: NOVN) and Globus Medical (NYSE: GMED)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
ENOVEnovis
AXGNAxoGen
NGNENeurogene
ONCBeOne Medicines
OCGNOcugen
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Globus Medical

3 Months
Jason WittesRoth MKM
Success Rate
15/23 ratings generated profit
65%
Average Return
+4.55%
Copying Jason Wittes's trades and holding each position for 3 Months would result in 65.22% of your transactions generating a profit, with an average return of +4.55% per trade.
1 Year
Caitlin CroninCanaccord Genuity
Success Rate
9/13 ratings generated profit
69%
Average Return
+16.61%
Copying Caitlin Cronin's trades and holding each position for 1 Year would result in 69.23% of your transactions generating a profit, with an average return of +16.61% per trade.
2 Years
Caitlin CroninCanaccord Genuity
Success Rate
10/13 ratings generated profit
77%
Average Return
+22.06%
Copying Caitlin Cronin's trades and holding each position for 2 Years would result in 76.92% of your transactions generating a profit, with an average return of +22.06% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

GM0N Analyst Recommendation Trends

Rating
Mar 26
Apr 26
May 26
Jun 26
Jul 26
Strong Buy
0
0
2
2
2
Buy
24
13
9
10
11
Hold
6
2
1
2
4
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
30
15
12
14
17
In the current month, GM0N has received 13 Buy Ratings, 4 Hold Ratings, and 0 Sell Ratings. GM0N average Analyst price target in the past 3 months is 93.85.
Each month's total comprises the sum of three months' worth of ratings.

GM0N Financial Forecast

GM0N Earnings Forecast

Next quarter’s earnings estimate for GM0N is €0.96 with a range of €0.92 to €1.00. The previous quarter’s EPS was €0.98. GM0N beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.81% of the time in the same period. In the last calendar year GM0N has Performed in-line its overall industry.
Next quarter’s earnings estimate for GM0N is €0.96 with a range of €0.92 to €1.00. The previous quarter’s EPS was €0.98. GM0N beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.81% of the time in the same period. In the last calendar year GM0N has Performed in-line its overall industry.

GM0N Sales Forecast

Next quarter’s sales forecast for GM0N is €684.61M with a range of €676.63M to €690.80M. The previous quarter’s sales results were €664.52M. GM0N beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 48.70% of the time in the same period. In the last calendar year GM0N has Performed in-line its overall industry.
Next quarter’s sales forecast for GM0N is €684.61M with a range of €676.63M to €690.80M. The previous quarter’s sales results were €664.52M. GM0N beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 48.70% of the time in the same period. In the last calendar year GM0N has Performed in-line its overall industry.

GM0N Stock Forecast FAQ

What is DE:GM0N’s average 12-month price target, according to analysts?
Based on analyst ratings, Globus Medical’s 12-month average price target is 93.85.
    What is DE:GM0N’s upside potential, based on the analysts’ average price target?
    Globus Medical has 20.59% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Globus Medical a Buy, Sell or Hold?
          Globus Medical has a consensus rating of Strong Buy, which is based on 9 buy ratings, 2 hold ratings and 0 sell ratings.
            What is Globus Medical’s share price target?
            The average share price target for Globus Medical is 93.85. This is based on 11 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is €107.99 ,and the lowest forecast is €70.24. The average share price target represents 20.59% Increase from the current price of €77.82.
              What do analysts say about Globus Medical?
              Globus Medical’s analyst rating consensus is a Strong Buy. This is based on the ratings of 11 Wall Streets Analysts.
                How can I buy shares of Globus Medical?
                To buy shares of DE:GM0N, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.